In vitro characterization of rare anti-αIIbβ3 isoantibodies produced by patients with Glanzmann thrombasthenia that severely block fibrinogen binding and generate procoagulant platelets via complement activation [PDF]
Res Pract Thromb Haemost, 2023 Glanzmann thrombasthenia (GT) is a rare bleeding disorder caused by inherited defects of the platelet αβ integrin. Platelet transfusions can be followed by an immune response that can block integrin function by interfering with fibrinogen binding.
Christine S.M. Lee +7 more
europepmc +6 more sources
Evidence for an influence of secretor status on levels of the ABO-isoantibodies in serum
Asian Journal of Transfusion Science, 2015 SanmukhR Joshi +2 more
exaly +4 more sources
QUANTITATIVE STUDIES OF THE SENSITIVITY OF NORMAL AND NEOPLASTIC MOUSE CELLS TO THE CYTOTOXIC ACTION OF ISOANTIBODIES [PDF]
, 1962 Experiments were performed to study the mechanisms of the sensitivity of normal and neoplastic mouse cells to the cytotoxic action of humoral isoantibodies. A quantitative in vitro absorption procedure was used to compare the residua] hemagglutinin titer
Erna Möller, Göran Möller
openalex +4 more sources
Prevalence of a Novel Immunogenic Feline Erythrocyte Antigen (FEA 6) and Expression Patterns Between FEAs [PDF]
Journal of Veterinary Internal Medicine, Volume 39, Issue 3, May/June 2025.ABSTRACT Background After the identification of five novel feline erythrocyte antigens (FEAs) and evidence establishing FEA 1's immunogenicity, attempts to sensitize a cat to FEA 4 unexpectedly resulted in the production of alloantibodies directed against an unknown antigen, named FEA 6.
Félix Bajon +2 more
wiley +2 more sources
THE PRODUCTION OF ISOANTIBODIES IN THE DOG BY IMMUNIZATION WITH HOMOLOGOUS TISSUE
Transplantation, 1964 Kasakura S +4 more
openaire +4 more sources
Association of the blood groups with mostly public Diseases
Kufa Journal for Nursing Sciences, 2021 The ABO blood group system is identified in 1900. Its principle that antigens as sugars physically exposed on the exterior of red blood cells *RBCs* differ between individuals, who have immunological tolerance only toward what occurs in their own bodies.
Nagham Ghafel
doaj +1 more source
Transfusion management of patients with alloanti-Gerbich antibodies: Case report [PDF]
Srpski Arhiv za Celokupno Lekarstvo, 2011 Introduction. Transfusion management of patients who are alloimmunized against high-prevalence erythrocyte antigens is often problematic. Strategy management depends, not only on the specific clinical circumstances of the patient, but also on the ...
Jovanović Radmila +3 more
doaj +1 more source
Journal of Applied Hematology, 2020 BACKGROUND: The clinical significance of anti-A1antibody among A2and A2B subgroups is controversial. Few case reports have shown clinically significant anti-A1antibody at 37°C, causing hemolysis of donor red cells.
Debasish Mishra +6 more
doaj +1 more source
Oman Medical Journal, 2020 Objectives: Red blood cell (RBC) immunization is a common complication in blood transfusion recipients. Patients with chronic kidney disease (CKD) eventually develop anemia, which is multifactorial, and requires regular blood transfusions, which exposes ...
Shafini Mohamed Yusoff +5 more
doaj +1 more source
Revista Portuguesa de Nefrologia e Hipertensão, 2023 The diagnosis of antibody-mediated rejection has become more common and represents a major cause of kidney graft loss. The ideal treatment remains unknown, with little evidence supporting the use of a specific therapy.
Rita M. Silva +7 more
doaj +1 more source